http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 17 Jul 2026 17:36:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+17++Filed+by%3A+OYLER+JOHN/26785293.html si-local-file:///var/storage/secattach/20260717/26785293.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+17++Filed+by%3A+OYLER+JOHN/26785293.html Fri, 17 Jul 2026 17:36:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+17++Filed+by%3A+OYLER+JOHN/26785293.html si-local-file:///var/storage/secattach/20260717/26785293.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+17++Filed+by%3A+OYLER+JOHN/26785293.html Fri, 17 Jul 2026 17:36:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+17++Filed+by%3A+OYLER+JOHN/26785293.html si-local-file:///var/storage/secattach/20260717/26785293.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+17++Filed+by%3A+OYLER+JOHN/26785293.html Fri, 17 Jul 2026 17:36:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+15++Filed+by%3A+OYLER+JOHN/26785288.html si-local-file:///var/storage/secattach/20260717/26785288.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+15++Filed+by%3A+OYLER+JOHN/26785288.html Fri, 17 Jul 2026 17:31:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+15++Filed+by%3A+OYLER+JOHN/26785288.html si-local-file:///var/storage/secattach/20260717/26785288.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+15++Filed+by%3A+OYLER+JOHN/26785288.html Fri, 17 Jul 2026 17:31:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+15++Filed+by%3A+OYLER+JOHN/26785288.html si-local-file:///var/storage/secattach/20260717/26785288.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+15++Filed+by%3A+OYLER+JOHN/26785288.html Fri, 17 Jul 2026 17:31:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/Press+Releases/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html <p> SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. </p><p> The live webcast of this event can be accessed from the investors section of the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.beonemedicines.com&amp;esheet=54572041&amp;newsitemid=20260717984937&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.beonemedicines.com&amp;index=1&amp;md5=f0e4cac4a208ac5c7fe84df748fe2b86" shape="rect">https://ir.beonemedicines.com</a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An http://www.streetinsider.com/Press+Releases/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html Fri, 17 Jul 2026 06:01:00 -0400 06160 688235 O.76306903 ONC http://www.streetinsider.com/Press+Releases/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html <p> SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. </p><p> The live webcast of this event can be accessed from the investors section of the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.beonemedicines.com&amp;esheet=54572041&amp;newsitemid=20260717984937&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.beonemedicines.com&amp;index=1&amp;md5=f0e4cac4a208ac5c7fe84df748fe2b86" shape="rect">https://ir.beonemedicines.com</a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An http://www.streetinsider.com/Press+Releases/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html Fri, 17 Jul 2026 06:01:00 -0400 06160 688235 O.76306903 ONC http://www.streetinsider.com/Press+Releases/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html <p> SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. </p><p> The live webcast of this event can be accessed from the investors section of the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.beonemedicines.com&amp;esheet=54572041&amp;newsitemid=20260717984937&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.beonemedicines.com&amp;index=1&amp;md5=f0e4cac4a208ac5c7fe84df748fe2b86" shape="rect">https://ir.beonemedicines.com</a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An http://www.streetinsider.com/Press+Releases/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html Fri, 17 Jul 2026 06:01:00 -0400 06160 688235 O.76306903 ONC http://www.streetinsider.com/Press+Releases/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html <p> SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. </p><p> The live webcast of this event can be accessed from the investors section of the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.beonemedicines.com&amp;esheet=54572041&amp;newsitemid=20260717984937&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.beonemedicines.com&amp;index=1&amp;md5=f0e4cac4a208ac5c7fe84df748fe2b86" shape="rect">https://ir.beonemedicines.com</a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An http://www.streetinsider.com/Press+Releases/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html Fri, 17 Jul 2026 06:01:00 -0400 06160 688235 O.76306903 ONC http://www.streetinsider.com/Business+Wire/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html <p> SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. </p><p> The live webcast of this event can be accessed from the investors section of the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.beonemedicines.com&amp;esheet=54572041&amp;newsitemid=20260717984937&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.beonemedicines.com&amp;index=1&amp;md5=f0e4cac4a208ac5c7fe84df748fe2b86" shape="rect">https://ir.beonemedicines.com</a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An http://www.streetinsider.com/Business+Wire/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html Fri, 17 Jul 2026 06:01:00 -0400 06160 688235 O.76306903 ONC http://www.streetinsider.com/Business+Wire/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html <p> SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. </p><p> The live webcast of this event can be accessed from the investors section of the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.beonemedicines.com&amp;esheet=54572041&amp;newsitemid=20260717984937&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.beonemedicines.com&amp;index=1&amp;md5=f0e4cac4a208ac5c7fe84df748fe2b86" shape="rect">https://ir.beonemedicines.com</a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An http://www.streetinsider.com/Business+Wire/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html Fri, 17 Jul 2026 06:01:00 -0400 06160 688235 O.76306903 ONC http://www.streetinsider.com/Business+Wire/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html <p> SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. </p><p> The live webcast of this event can be accessed from the investors section of the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.beonemedicines.com&amp;esheet=54572041&amp;newsitemid=20260717984937&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.beonemedicines.com&amp;index=1&amp;md5=f0e4cac4a208ac5c7fe84df748fe2b86" shape="rect">https://ir.beonemedicines.com</a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An http://www.streetinsider.com/Business+Wire/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html Fri, 17 Jul 2026 06:01:00 -0400 06160 688235 O.76306903 ONC http://www.streetinsider.com/Business+Wire/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html <p> SAN CARLOS, Calif.--(BUSINESS WIRE)-- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. </p><p> The live webcast of this event can be accessed from the investors section of the Company’s website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.beonemedicines.com&amp;esheet=54572041&amp;newsitemid=20260717984937&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.beonemedicines.com&amp;index=1&amp;md5=f0e4cac4a208ac5c7fe84df748fe2b86" shape="rect">https://ir.beonemedicines.com</a>. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An http://www.streetinsider.com/Business+Wire/BeOne+Medicines+to+Announce+Second+Quarter+2026+Financial+Results+on+August+5/26781348.html Fri, 17 Jul 2026 06:01:00 -0400 06160 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+14++Filed+by%3A+OYLER+JOHN/26769472.html si-local-file:///var/storage/secattach/20260714/26769472.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+14++Filed+by%3A+OYLER+JOHN/26769472.html Tue, 14 Jul 2026 21:27:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+14++Filed+by%3A+OYLER+JOHN/26769472.html si-local-file:///var/storage/secattach/20260714/26769472.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+14++Filed+by%3A+OYLER+JOHN/26769472.html Tue, 14 Jul 2026 21:27:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+14++Filed+by%3A+OYLER+JOHN/26769472.html si-local-file:///var/storage/secattach/20260714/26769472.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+14++Filed+by%3A+OYLER+JOHN/26769472.html Tue, 14 Jul 2026 21:27:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+10++Filed+by%3A+OYLER+JOHN/26769471.html si-local-file:///var/storage/secattach/20260714/26769471.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+10++Filed+by%3A+OYLER+JOHN/26769471.html Tue, 14 Jul 2026 21:25:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+10++Filed+by%3A+OYLER+JOHN/26769471.html si-local-file:///var/storage/secattach/20260714/26769471.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+10++Filed+by%3A+OYLER+JOHN/26769471.html Tue, 14 Jul 2026 21:25:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+10++Filed+by%3A+OYLER+JOHN/26769471.html si-local-file:///var/storage/secattach/20260714/26769471.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BeOne+Medicines+Ltd.++++++For%3A+Jul+10++Filed+by%3A+OYLER+JOHN/26769471.html Tue, 14 Jul 2026 21:25:00 -0400 688235 O.76306903 ONC http://www.streetinsider.com/Analyst+PT+Change/BeOne+Medicines+%28ONC%29+PT+Lowered+to+%24403+at+Barclays/26763873.html Barclays analyst Peter Lawson lowered the price target on BeOne Medicines (NASDAQ: ONC) to $403.00 (from $409.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/BeOne+Medicines+%28ONC%29+PT+Lowered+to+%24403+at+Barclays/26763873.html Tue, 14 Jul 2026 05:11:33 -0400 ONC http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+BeOne+Medicines+%28ONC%29+to+Buy/26758721.html <p>Jefferies analyst Faisal Khurshid upgraded BeOne Medicines (NASDAQ: ONC) from Hold to Buy with a price target of $380.00 (from $333.00).</p><p>The analyst comments: “Time to be positive on BeOne. Our HOLD thesis was based on: (1) CLL leadership already well appreciated + incoming CLL competition from AV and Jaypirca, and (2) no clear winner in the solid tumor pipeline. On (1), coming out of EHA we think Brukinsa will maintain dominance and ZS will emerge as preferred combo. We see real upside to Brukinsa consensus. On (2), CDK4, GPC3, B7-H4 each had good updates and we see enough to start http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+BeOne+Medicines+%28ONC%29+to+Buy/26758721.html Mon, 13 Jul 2026 02:19:11 -0400 ONC http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+BeOne+Medicines+%28ONC%29+to+Buy/26758721.html <p>Jefferies analyst Faisal Khurshid upgraded BeOne Medicines (NASDAQ: ONC) from Hold to Buy with a price target of $380.00 (from $333.00).</p><p>The analyst comments: “Time to be positive on BeOne. Our HOLD thesis was based on: (1) CLL leadership already well appreciated + incoming CLL competition from AV and Jaypirca, and (2) no clear winner in the solid tumor pipeline. On (1), coming out of EHA we think Brukinsa will maintain dominance and ZS will emerge as preferred combo. We see real upside to Brukinsa consensus. On (2), CDK4, GPC3, B7-H4 each had good updates and we see enough to start http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+BeOne+Medicines+%28ONC%29+to+Buy/26758721.html Mon, 13 Jul 2026 02:19:11 -0400 ONC http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+BeOne+Medicines+%28ONC%29+to+Buy/26758722.html <p>Jefferies analyst Faisal Khurshid upgraded BeOne Medicines (NASDAQ: ONC) from Hold to Buy with a price target of $380.00 (from $333.00).</p><p>The analyst comments: “Time to be positive on BeOne. Our HOLD thesis was based on: (1) CLL leadership already well appreciated + incoming CLL competition from AV and Jaypirca, and (2) no clear winner in the solid tumor pipeline. On (1), coming out of EHA we think Brukinsa will maintain dominance and ZS will emerge as preferred combo. We see real upside to Brukinsa consensus. On (2), CDK4, GPC3, B7-H4 each had good updates and we see enough to start http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+BeOne+Medicines+%28ONC%29+to+Buy/26758722.html Mon, 13 Jul 2026 02:19:11 -0400 ONC http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+BeOne+Medicines+%28ONC%29+to+Buy/26758722.html <p>Jefferies analyst Faisal Khurshid upgraded BeOne Medicines (NASDAQ: ONC) from Hold to Buy with a price target of $380.00 (from $333.00).</p><p>The analyst comments: “Time to be positive on BeOne. Our HOLD thesis was based on: (1) CLL leadership already well appreciated + incoming CLL competition from AV and Jaypirca, and (2) no clear winner in the solid tumor pipeline. On (1), coming out of EHA we think Brukinsa will maintain dominance and ZS will emerge as preferred combo. We see real upside to Brukinsa consensus. On (2), CDK4, GPC3, B7-H4 each had good updates and we see enough to start http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+BeOne+Medicines+%28ONC%29+to+Buy/26758722.html Mon, 13 Jul 2026 02:19:11 -0400 ONC